{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:17:06Z","timestamp":1784193426975,"version":"3.55.0"},"reference-count":16,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,4,1]]},"abstract":"<jats:p>Since October 3, 2001, the Centers for Disease Control and Prevention and other organizations have been investigating potential bioterrorist-related anthrax cases. The pediatrician may be faced with complex issues related to diagnosis and treatment of illnesses caused by intentionally released biological agents. The agents that pose a major potential bioterrorist threat are reviewed by the clinical syndromes they produce: acute respiratory distress with fever, influenza-like illnesses, acute rash with fever, neurologic syndromes, and blistering syndromes. Specific and detailed diagnostic, treatment, and prophylaxis information is provided for anthrax, plague, tularemia, smallpox, botulism, viral hemorrhagic fevers, and other diseases. In cases of suspected bioterrorism, the pediatrician must be able to obtain diagnostic and treatment information efficiently and expeditiously. The system controlling the interaction between public and nonpublic health laboratories in suspected cases of bioterrorism is described. Finally, information regarding emergency contacts and links to educational resources is provided.<\/jats:p>","DOI":"10.1542\/peds.109.4.685","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:17:55Z","timestamp":1092442675000},"page":"685-692","source":"Crossref","is-referenced-by-count":37,"title":["Diagnosis and Management of Suspected Cases of Bioterrorism: A Pediatric Perspective"],"prefix":"10.1542","volume":"109","author":[{"given":"Hanoch A.","family":"Patt","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics, Baylor College of Medicine, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph D.","family":"Feigin","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Baylor College of Medicine, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2002,4,1]]},"reference":[{"key":"2021121006211843500_R1","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Environmental Health and Committee on Infectious Diseases. Chemical-biological terrorism and its impact on children: a subject review. Pediatrics.2000;105:662\u2013670","DOI":"10.1542\/peds.105.3.662"},{"key":"2021121006211843500_R2","unstructured":"Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR Morb Mortal Wkly Rep.2000;49(RR-4):1\u201314"},{"key":"2021121006211843500_R3","unstructured":"American Academy of Pediatrics. Pickering LK, ed. 2000 Red Book: Report of the Committee on Infectious Diseases. 25th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2000"},{"key":"2021121006211843500_R4","unstructured":"Kortepeter M, Christopher G, Cieslak T, et al, eds. USAMRIID\u2019s Medical Management of Biological Casualties Handbook. 4th ed. Fort Detrick, Frederick, MD: US Army Medical Research Institute of Infectious Diseases; 2001. Available at http:\/\/www.usamriid.army.mil\/education\/bluebook.html. Accessed February 12, 2002"},{"key":"2021121006211843500_R5","unstructured":"Update: investigation of bioterrorism-related anthrax, 2001. MMWR Morb Mortal Wkly Rep.2001;50:1008\u20131010"},{"key":"2021121006211843500_R6","unstructured":"World Health Organization Group of Consultants. Health Aspects of Chemical and Biological Weapons. Geneva, Switzerland: World Health Organization; 1970"},{"key":"2021121006211843500_R7","doi-asserted-by":"crossref","unstructured":"Cieslak TJ, Eitzen EM. Clinical and epidemiologic principles of anthrax. Emerg Infect Dis.2000;5:552\u2013555","DOI":"10.3201\/eid0504.990418"},{"key":"2021121006211843500_R8","unstructured":"Centers for Disease Control and Prevention, American Society for Microbiology, and Association of Public Health Laboratories. Basic diagnostic testing protocols for Level A Laboratories for the presumptive identification of Bacillus anthracis. Available at: http:\/\/www.asmusa.org\/pcsrc\/biodetection.htm Accessed November 20, 2001"},{"key":"2021121006211843500_R9","doi-asserted-by":"crossref","unstructured":"Swartz MN. Recognition and management of anthrax\u2014an update. N Engl J Med.2001;345:1621\u20131626","DOI":"10.1056\/NEJMra012892"},{"key":"2021121006211843500_R10","doi-asserted-by":"crossref","unstructured":"Inglesby TV, Henderson DA, Dennis DT, et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA.2001;283:2281\u20132290","DOI":"10.1001\/jama.283.17.2281"},{"key":"2021121006211843500_R11","doi-asserted-by":"crossref","unstructured":"Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. Working Group of Civilian Biodefense. JAMA.2001;285:2763\u20132773","DOI":"10.1001\/jama.285.21.2763"},{"key":"2021121006211843500_R12","unstructured":"Young EJ. Brucellosis. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. 4th ed. Philadelphia, PA: WB Saunders Co;1998:1417\u20131423"},{"key":"2021121006211843500_R13","doi-asserted-by":"crossref","unstructured":"Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA.1999;281:2127\u20132137","DOI":"10.1001\/jama.281.22.2127"},{"key":"2021121006211843500_R14","doi-asserted-by":"crossref","unstructured":"Cohen J. Smallpox vaccinations: how much protection remains?Science.2001;294:985","DOI":"10.1126\/science.294.5544.985"},{"key":"2021121006211843500_R15","unstructured":"American Society for Microbiology. Basic protocols for level A laboratories for botulinum toxin. Available at: http:\/\/www.asm.org\/pcsrc\/biodetection.htm Accessed December 7, 2001"},{"key":"2021121006211843500_R16","unstructured":"American Society for Microbiology. Level. A protocols\u2013laboratory response network. Available at: http:\/\/www.asmusa.org\/pcsrc\/biodetection.htm. Accessed November 20, 2001"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/109\/4\/685\/1114565\/pe0402000685.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/109\/4\/685\/1114565\/pe0402000685.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T14:23:54Z","timestamp":1639146234000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/109\/4\/685\/64104\/Diagnosis-and-Management-of-Suspected-Cases-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4,1]]},"references-count":16,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2002,4,1]]},"published-print":{"date-parts":[[2002,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.109.4.685","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4,1]]}}}